why choose us

Clinical Trials Search

Showing 4,150 of 132,963 result(s)
Effect of a Nutritional Supplement With Phytoglycogen on Gut-brain Axis With Focus to Perceived Stress, Mood and Sleep

Status: COMPLETED

Condition: Perceived Stress

Interventions: microcrystalline cellulose; 200 mg ;day; 1 capsule;day; 1 capsule daily with breakfast

Date: 2024-09-27

A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy

Status: COMPLETED

Condition: Acute Pain

Interventions: Tablets for oral administration.

Date: 2024-09-27

Efficacy Study of the Probiotic Food Supplement PROBAFLOR for Maintaining Intestinal Well-being

Status: COMPLETED

Condition: Gut

Interventions: PROBAFLOR is a food supplement made up of 11 bacterial strains and inulin.
The bacterial strains present are: Bifidobacterium lactis BLC1, Lactoc

Date: 2024-09-26

AZAHAR Study To Describe Anifrolumab in a Real-World Setting

Status: COMPLETED

Condition: Systemic Lupus Erythematosus (SLE)

Interventions:

Date: 2024-09-26

AZAHAR Study To Describe Anifrolumab in a Real-World Setting

Status: COMPLETED

Condition: Systemic Lupus Erythematosus (SLE)

Interventions:

Date: 2024-09-26

Comparing Optimized Models of Primary And Specialist Services for Palliative Care: Pilot Feasibility Trial

Status: COMPLETED

Condition: Seriously Ill Hospitalized Patients

Interventions: A specialist PC consult is automatically ordered for patients meeting a certain threshold of 1-year mortality risk (dependent on arm).
An EHR-bas

Date: 2024-09-26

Ultrasound Assessment of Myofascial Trigger Points

Status: COMPLETED

Condition: Myofascial Pain

Interventions: Both groups of participants-those with myofascial and;or musculoskeletal pain and those without musculoskeletal alterations-will undergo a standa

Date: 2024-09-26

Impact of Alpine Dairy Products on Blood Lipid Levels

Status: COMPLETED

Condition: Elevated Cholesterol

Interventions: The intervention group will be instructed to eat three portions of alpine dairy products daily.
The proposed three portions represent an estimate

Date: 2024-09-26

Neoadjuvant Toripalimab Plus Docetaxel and Carboplatin in Patients With Localized TNBC (NeoTOP)

Status: COMPLETED

Condition: Breast Cancer

Interventions: Toripalimab was given 240 mg intravenously on day 1 of each 21-day cycle for 6 cycles.

Date: 2024-09-26

Wingspan Stent System for Intracranial Artery Stenosis

Status: COMPLETED

Condition: Intracranial Artery Stenosis

Interventions: All patients had received Percutaneous transluminal angioplasty and stenting with Wingspan stent system.

Date: 2024-09-26